Connection
Angela Myers to Antiviral Agents
This is a "connection" page, showing publications Angela Myers has written about Antiviral Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.256 |
|
|
|
-
Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report. Pediatrics. 2024 Oct 01; 154(4).
Score: 0.952
-
Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement. Pediatrics. 2024 Oct 01; 154(4).
Score: 0.952
-
Otto WR, Myers AL, LaRussa B, Kimberlin DW, Jackson MA. Clinical Markers and Outcomes of Neonates With Herpes Simplex Virus Deoxyribonucleic Acid Persistence in Cerebrospinal Fluid in Disseminated and Central Nervous System Infection. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):e30-e33.
Score: 0.153
-
Torres-Torres S, Myers AL, Klatte JM, Rhoden EE, Oberste MS, Collett MS, McCulloh RJ. First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. Pediatr Infect Dis J. 2015 Jan; 34(1):52-4.
Score: 0.121
-
Caserta MT, O'Leary ST, Munoz FM, Ralston SL. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics. 2023 Jul 01; 152(1).
Score: 0.055
-
Williams DJ, Hall M, Brogan TV, Farris RW, Myers AL, Newland JG, Shah SS. Influenza coinfection and outcomes in children with complicated pneumonia. Arch Pediatr Adolesc Med. 2011 Jun; 165(6):506-12.
Score: 0.023